This elaborate regulation of IRF5 promoter usage leads to increases in both IRF5-short transcripts and ensemble gene expression of IRF5, ultimately resulting in monocyte/macrophage dysfunction and high autoimmune disease risk. The gene discussed is IRF5; the disease is autoimmune disease.